N4BP1 negatively regulates NF-κB by binding and inhibiting NEMO oligomerization

Nat Commun. 2021 Mar 2;12(1):1379. doi: 10.1038/s41467-021-21711-5.

Abstract

Many immune responses depend upon activation of NF-κB, an important transcription factor in the elicitation of a cytokine response. Here we show that N4BP1 inhibits TLR-dependent activation of NF-κB by interacting with the NF-κB signaling essential modulator (NEMO, also known as IκB kinase γ) to attenuate NEMO-NEMO dimerization or oligomerization. The UBA-like (ubiquitin associated-like) and CUE-like (ubiquitin conjugation to ER degradation-like) domains in N4BP1 mediate interaction with the NEMO COZI domain. Both in vitro and in mice, N4bp1 deficiency specifically enhances TRIF-independent (TLR2, TLR7, or TLR9-mediated) but not TRIF-dependent (TLR3 or TLR4-mediated) NF-κB activation, leading to increased production of proinflammatory cytokines. In response to TLR4 or TLR3 activation, TRIF causes activation of caspase-8, which cleaves N4BP1 distal to residues D424 and D490 and abolishes its inhibitory effect. N4bp1-/- mice also have diminished numbers of T cells in the peripheral blood. Our work identifies N4BP1 as an inhibitory checkpoint protein that must be overcome to activate NF-κB, and a TRIF-initiated caspase-8-dependent mechanism by which this is accomplished.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptor Proteins, Vesicular Transport / metabolism
  • Animals
  • Carrier Proteins / chemistry
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism*
  • Caspase 8 / metabolism
  • Female
  • Gene Expression Regulation / drug effects
  • HEK293 Cells
  • Herpesvirus 1, Human / physiology
  • Humans
  • Interleukin-6 / blood
  • Intracellular Signaling Peptides and Proteins / metabolism*
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mutation / genetics
  • NF-KappaB Inhibitor alpha / metabolism
  • NF-kappa B / metabolism*
  • Oligodeoxyribonucleotides / pharmacology
  • Phosphorylation / drug effects
  • Protein Binding / drug effects
  • Protein Domains
  • Protein Multimerization* / drug effects
  • Signal Transduction / drug effects
  • Ubiquitin / metabolism

Substances

  • Adaptor Proteins, Vesicular Transport
  • CPG-oligonucleotide
  • Carrier Proteins
  • Interleukin-6
  • Intracellular Signaling Peptides and Proteins
  • N4BP1 protein, mouse
  • NEMO protein, mouse
  • NF-kappa B
  • Oligodeoxyribonucleotides
  • TICAM-1 protein, mouse
  • Ubiquitin
  • NF-KappaB Inhibitor alpha
  • Caspase 8